Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Dig Dis Sci ; 60(10): 2901-12, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25999247

ABSTRACT

Helicobacter pylori (H. pylori) is one of the leading causes of gastric diseases such as chronic gastritis, peptic ulcer, and gastric adenocarcinoma. The current treatment of H. pylori infection with antibiotics and proton pump inhibitors has several limitations, including poor adherence and intrinsic patient-related factors, drug resistance, and the absence of adequate treatments. This review summarizes the current therapeutic approaches to eradicating H. pylori, the difficulties associated with its treatment, and several new perspectives aimed at improving existing treatment strategies.


Subject(s)
Adenocarcinoma/prevention & control , Helicobacter Infections/complications , Helicobacter Infections/drug therapy , Helicobacter pylori/drug effects , Stomach Neoplasms/prevention & control , Anti-Bacterial Agents/administration & dosage , Drug Therapy, Combination , Female , Gastritis/drug therapy , Gastritis/etiology , Helicobacter pylori/isolation & purification , Humans , Male , Peptic Ulcer/drug therapy , Peptic Ulcer/etiology , Prognosis , Proton Pump Inhibitors/therapeutic use , Risk Assessment , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL